Microbial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity [Human_Multiome_Cohort2
Ontology highlight
ABSTRACT: Microbial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity [Human_Multiome_Cohort2
PROVIDER: PRJNA1254163 | ENA |
REPOSITORIES: ENA
ACCESS DATA